DARSHAN SEHBI: Open Payments
NPI 1851370696 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,083 in 117 payments from 11 companies in 2025. Trend: 2023 $4,501 · 2024 $4,491 · 2025 $3,083
Food & beverage: $3,079Education: $4
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $757 |
| Janssen Pharmaceuticals, Inc | 11 | $519 |
| Teva Pharmaceuticals USA, Inc. | 11 | $398 |
| Alkermes, Inc. | 12 | $276 |
| Otsuka America Pharmaceutical, Inc. | 13 | $239 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $207 |
| Vanda Pharmaceuticals Inc. | 12 | $200 |
| ABBVIE INC. | 17 | $156 |
| Axsome Therapeutics, Inc. | 5 | $119 |
| Lundbeck LLC | 5 | $114 |
Products named: COBENFY, REXULTI, ARISTADA, SPRAVATO, INVEGA SUSTENNA, UZEDY, CAPLYTA, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
